Changes in the white blood cell count. حسب Lu Yang (30847)

"…The incidence of bone pain in the experimental group was 34.1%, of which most were mild bone pain, and no severe bone pain occurred. …"

Changes in the hemoglobin. حسب Lu Yang (30847)

"…The incidence of bone pain in the experimental group was 34.1%, of which most were mild bone pain, and no severe bone pain occurred. …"

WBC and ANC on day 7 post-chemotherapy. حسب Lu Yang (30847)

"…The incidence of bone pain in the experimental group was 34.1%, of which most were mild bone pain, and no severe bone pain occurred. …"

General clinical data of 88 patients with NPC. حسب Lu Yang (30847)

"…The incidence of bone pain in the experimental group was 34.1%, of which most were mild bone pain, and no severe bone pain occurred. …"

CONSORT participant flow diagram. حسب Lu Yang (30847)

"…The incidence of bone pain in the experimental group was 34.1%, of which most were mild bone pain, and no severe bone pain occurred. …"

S4 File - حسب Lu Yang (30847)

"…The incidence of bone pain in the experimental group was 34.1%, of which most were mild bone pain, and no severe bone pain occurred. …"

IFA disarmed capsule-mediated immune evasion. حسب Tingting Wang (123983)

IFA reduced the capsular biosynthesis through altering bacterial metabolism. حسب Tingting Wang (123983)

Clinical characteristics. حسب Clemens Plattner (21567706)

"…FHD was associated with increased risk for neuropathy (HR 1.41 [95%CI 1.11–1.81]) but decreased risk for macrovascular disease (HR 0.84 [95%CI 0.71–0.99]). …"

Pneumococcal (black bars) and influenza (white bars) vaccine coverage in patients living with comorbidities (A), and immunosuppressive conditions (B) according to age of 65 years,... حسب Benjamin Wyplosz (22032756)

Genes correlated with SARS-CoV-2 viral load over time are similarly expressed in independent datasets of SARS-CoV-2 infected lung and upper airway cells. حسب Vasanthi Avadhanula (259546)

Differential gene sets associated with the transcriptional host response to SARS-CoV-2 infection across serially collected samples. حسب Vasanthi Avadhanula (259546)

Cascade of care by HCV testing model. حسب Bao Vu Ngoc (14551955)

"…Among 2,882 participants tested for HCV, 1,834 used HCVST and 1,048 used standard HCVT. …"

Factors associated with first-time HCV testing. حسب Bao Vu Ngoc (14551955)

"…Among 2,882 participants tested for HCV, 1,834 used HCVST and 1,048 used standard HCVT. …"

Raw data. حسب Yin Jie (21464235)

"…In conclusion, this study revealed that 1’,4’-<i>trans</i>-diol-ABA may perform a significant function in increasing crop salt-stress tolerance.…"

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. حسب Masashi Okawa (8951294)

"…<b>c</b> Further addition of bevacizumab to serum samples post-bevacizumab administration significantly decreased VEGF-A121 levels in samples to which 20 and 200 μg/mL bevacizumab was added (ANOVA: <i>p</i> < 0.0001; Dunnett’s multiple comparisons test: +2 μg/mL, <i>p</i> = 0.7096 vs control; +20 μg/mL, <i>p</i> = 0.0107 vs control; +200 μg/mL, <i>p</i> < 0.0001 vs control). …"

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. حسب Masashi Okawa (8951294)

Comparison of biological and socioeconomic risk factors of maternal mortality, in Pakistan (PDHS 2007 and PMMS 2019) (see note 1). حسب Farid Midhet (17403945)

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. حسب Masashi Okawa (8951294)

VEGF-A121, VEGF-A165, and VEGF-A contents per unit platelets. حسب Masashi Okawa (8951294)